| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| March 26, 2026 | ±3.7% | +0.3% | over-priced |
| December 22, 2025 | ±2.6% | +2.3% | over-priced |
| September 30, 2025 | ±1.7% | -1.4% | over-priced |
| March 26, 2025 | ±1.7% | +4.2% | under-priced |
| December 19, 2024 | ±2.1% | +1.4% | over-priced |
| October 1, 2024 | ±1.2% | +4.9% | under-priced |
| April 2, 2024 | ±1.5% | +0.4% | over-priced |
| December 21, 2023 | ±1.4% | -7.0% | under-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q3 FY2026 | $1.56 | $1.8B | $560M |
| Q2 FY2026 | $1.10 | $1.6B | $395M |
| Q1 FY2026 | $1.06 | $1.5B | $384M |
| Q4 FY2025 | $0.82 | $1.4B | $297M |
Paychex Inc (PAYX) reports in 36 days, with the next report estimated for July 19, 2026. Across the last 8 reports, options priced an average ±2.0% earnings move while the stock actually moved 2.7% on average — the market has been roughly fair on PAYX's earnings risk. Fundamentals into the print: EPS up 9.1% year-over-year, revenue up 19.9%. QuantLogix's live 5-factor engine currently reads PAYX as a buy at 64/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →